Names that match “THE TRUMP FOLLIES MEMBER INC”
4,673 documents found
Fwd: JUDGE SWEET ALLOWING STEVEN HOFFENBERG TO TALK WITH THE TOWERS VICTIMS TO EXPLAIN THE
email IMAGES-011-HOUSE_OVERSIGHT_031230.txt Jul 13, 2016 House Oversight Committee — Epstein Estate Records (Nov 2025)
… Epstein [[email protected]]; Bennet J. Moskowitz
Subject: Fwd: JUDGE SWEET ALLOWING STEVEN HOFFENBERG TO TALK WITH THE TOWERS VICTIMS TO EXPLAIN THE
VICTIMS SUIT FILING AGAINST JEFF EPSTEIN
DARREN K. INDYKE
DARREN K. INDYKE, PLLC
575 Lexington Avenue, 4th Floor
New York, N...
COLLABORATIVE INSIGHTS February 25, 2019
document IMAGES-008-HOUSE_OVERSIGHT_024902.txt Feb 25, 2019 House Oversight Committee — Epstein Estate Records (Nov 2025)
COWEN
COLLABORATIVE INSIGHTS February 25, 2019
The current licensed companies have already entered agreements with publicly traded
cannabis companies. In 2018, Aurora acquired Uruguayan fully licensed ICC Labs Inc.
(ICC) that operates a GMP-certified lab facility, indoor and out...
HBRK Associates Inc
document IMAGES-003-HOUSE_OVERSIGHT_016220.txt House Oversight Committee — Epstein Estate Records (Nov 2025)
Richard Kahn
HBRK Associates Inc.
575 Lexington Avenue, 4th Floor
New York, NY 10022
HOUSE_OVERSIGHT_016220
Inc.: Private Company Information - Bloomberg
document IMAGES-001-HOUSE_OVERSIGHT_012067.txt,11/14/2017 Rockefeller & Co. House Oversight Committee — Epstein Estate Records (Nov 2025)
Inc.: Private Company Information - Bloomberg
nett I, 274 F.Supp.2d at 104. Proximate
document IMAGES-004-HOUSE_OVERSIGHT_017891.txt House Oversight Committee — Epstein Estate Records (Nov 2025)
…l support this connection. See
Furst Nationurde Bank v. Gelt Funding
Corp., 27 F.3d 768, 769 (2d Cir.1994)
(“Central to the notion of proximate cause
is the idea that a person is not liable to all
those who may have been injured by his
conduct, but only to those with respect to
w...
Third, the report highlights how powerful bipartisan constituencies have emerged in the past to
document IMAGES-006-HOUSE_OVERSIGHT_020827.txt House Oversight Committee — Epstein Estate Records (Nov 2025)
Third, the report highlights how powerful bipartisan constituencies have emerged in the past to
tackle great issues for the betterment of our nation, including tax reform, civil liberties,
healthcare, education and national defense. Just as presidents of both parties rose to the...
High-Level Thoughts on
document IMAGES-006-HOUSE_OVERSIGHT_020854.txt House Oversight Committee — Epstein Estate Records (Nov 2025)
…Sheet
KP
CC —— USA Inc. | High Level Thoughts 25
How Would You Feel if...
...your Cash Flow was NEGATIVE for
each of the past 9 years...
... your Net Worth* has been
NEGATIVE for as long as you can
remember...
... t would take 20 years of your
income at the current level to...
Paul J. Set Theory and the Continuum Hypothesis. Dover Publications Inc
document Cohen House Oversight Committee — Epstein Estate Records (Nov 2025)
Paul J. Set Theory and the Continuum Hypothesis. Dover Publications Inc.
USA Inc.’s financial liabilities -- whether they are actual
document e Unless they are reduced House Oversight Committee — Epstein Estate Records (Nov 2025)
USA Inc.’s financial liabilities -- whether they are actual
and/or was involved in Novamente LLC and Webmind Inc
document involved with the OpenCog project House Oversight Committee — Epstein Estate Records (Nov 2025)
and/or was involved in Novamente LLC and Webmind Inc.
Inc. Therapeutics 7.7 19.4 - 19.4 2.51 2.51 581.9%
document Acadia Phamaceuticals House Oversight Committee — Epstein Estate Records (Nov 2025)
Inc. Therapeutics 7.7 19.4 - 19.4 2.51 2.51 581.9%
Inc. Therapeutics 2013 10.4 11.1 - 11.1 1.06 1.06 13.1%
document Ambit Biosciences House Oversight Committee — Epstein Estate Records (Nov 2025)
Inc. Therapeutics 2013 10.4 11.1 - 11.1 1.06 1.06 13.1%
Inc. Convergence 2011 88: 125 1.6 14.1 - 3.68 105.6%
document Audax Health Solutions House Oversight Committee — Epstein Estate Records (Nov 2025)
Inc. Convergence 2011 88: 125 1.6 14.1 - 3.68 105.6%
Inc. Therapeutics 2011 20.6 27.0 44.9 71.9 3.07 3.50 57.7%
document Chimerix House Oversight Committee — Epstein Estate Records (Nov 2025)
Inc. Therapeutics 2011 20.6 27.0 44.9 71.9 3.07 3.50 57.7%
Inc. Therapeutics 2013 3.4 6.8 - 6.8 2.03 2.03 1583.0%
document Epizyme House Oversight Committee — Epstein Estate Records (Nov 2025)
Inc. Therapeutics 2013 3.4 6.8 - 6.8 2.03 2.03 1583.0%